Extension Study in Subjects Who Relapsed After Complete Response on Study KW-0761-001

Summary

This study will enroll subjects with either Peripheral T-Cell Lymphoma (PTCL) or Cutaneous T-Cell Lymphoma(CTCL),including mycosis fungoides (MF) and Sezary Syndrome (SS), who have relapsed after achieving a complete response in study, KW-0761-001.

Timeline

Start

2010-08

Primary completion

2012-09

Completion

2012-09

Drugs

Indications